We are live on ! Find out more
AUTL

Autolus Therapeutics
AUTL

73 hedge funds and large institutions have $272M invested in Autolus Therapeutics in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

232% more call options, than puts

Call options by funds: $754K | Put options by funds: $227K

140% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 10

66% more capital invested

Capital invested by funds: $164M → $272M (+$108M)

37.65% more ownership

Funds ownership: 34.47% → 72.12% (+38%)

24% more funds holding

Funds holding: 59 → 73 (+14)

6% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 18

Holders
73
Holders Change
+14
Holders Change %
+23.73%
% of All Funds
1.12%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
19
Reduced
18
Closed
10
Calls
$754K
Puts
$227K
Net Calls
+$527K
Net Calls Change
-$28K

Top Buyers

Rank Fund Capital Flow
1
Blackstone Inc
Blackstone Inc
New York
+$108M
2
NCM
Nantahala Capital Management
Connecticut
+$6.85M
3
WP
Woodline Partners
California
+$5.63M
4
BlackRock
BlackRock
New York
+$1.93M
5
SG Americas Securities
SG Americas Securities
New York
+$1.51M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$4.23M
2
JP Morgan Chase
JP Morgan Chase
New York
-$3M
3
GIM
Granahan Investment Management
Massachusetts
-$1.16M
4
SM
Sabby Management
Florida
-$977K
5
Millennium Management
Millennium Management
New York
-$799K
Name Holding Trade Value Shares
Change 		Change in
Stake
William Blair & Company
51
William Blair & Company
Illinois
$58K +$67K +11,169 New
GSEP
52
Golden State Equity Partners
California
$55K +$63K +10,505 New
UBS Group
53
UBS Group
Switzerland
$47K +$9.33K +1,555 +21%
US Bancorp
54
US Bancorp
Minnesota
$37K +$16.3K +2,721 +61%
TRCT
55
Tower Research Capital (TRC)
New York
$23K -$9.89K -1,648 -27%
QCG
56
Quadrant Capital Group
Ohio
$20K +$2.21K +369 +11%
Group One Trading
57
Group One Trading
Illinois
$20K +$10.2K +1,700 +81%
Citigroup
58
Citigroup
New York
$9K -$8.73K -1,454 -45%
LC
59
Lindbrook Capital
California
$8K -$13.9K -2,314 -59%
HNB
60
Huntington National Bank
Ohio
$8K +$9.01K +1,501 New
TCWM
61
Total Clarity Wealth Management
Illinois
$6K -$18K -3,000 -71%
S
62
SignatureFD
Georgia
$6K -$14.1K -2,346 -66%
PA
63
Parallel Advisors
California
$6K +$6.84K +1,140 New
CFGS
64
Concourse Financial Group Securities
Alabama
$5K – – –
HNWAG
65
High Net Worth Advisory Group
Florida
$5K +$6K +1,000 New
UIA
66
Ulland Investment Advisors
Minnesota
$5K +$6K +1,000 New
CHA
67
Carmichael Hill & Associates
Maryland
$3K +$3.05K +508 New
Northwestern Mutual Wealth Management
68
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
ED
69
Exane Derivatives
France
$934 – – –
GIM
70
Granahan Investment Management
Massachusetts
– -$1.16M -176,683 Closed
JF
71
Jump Financial
Illinois
– -$432K -65,900 Closed
RCM
72
Regency Capital Management
Hawaii
– -$342K -57,000 Closed
RE
73
RBC Europe
United Kingdom
– -$303K -46,217 Closed
Acadian Asset Management
74
Acadian Asset Management
Massachusetts
– -$204K -31,289 Closed
New York State Common Retirement Fund
75
New York State Common Retirement Fund
New York
– -$177K -27,073 Closed
1 2
3
4

AUTL Hedge Fund Activity: Q4 2021 in Review

73 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Autolus Therapeutics (AUTL) for Q4 2021, worth a combined $272M — up 66% from $164M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new AUTL positions and 10 closed out — a net gain of 14 holders — while 19 added to existing stakes and 18 trimmed.

The largest buyer was Blackstone Inc, opening a new position worth an estimated $108M. The largest seller was Citadel Advisors, cutting an estimated $4.23M.

  • 73 institutional investors held Autolus Therapeutics (AUTL) as of Q4 2021, up from 59 in Q3 2021.
  • Funds reported $272M of Autolus Therapeutics stock for Q4 2021, up 66% quarter-over-quarter.
  • 24 funds opened new Autolus Therapeutics positions in Q4 2021 and 10 closed out, a net change of +14 holders.
  • The largest Autolus Therapeutics buyer in Q4 2021 was Blackstone Inc, an estimated $108M added.
  • The largest Autolus Therapeutics seller in Q4 2021 was Citadel Advisors, an estimated $4.23M sold.

Based on aggregated 13F filings for Q4 2021.